• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays

tetano

Editor, Senior Moderator
Virology. 2014 Dec 26;476C:151-158. doi: 10.1016/j.virol.2014.11.029. [Epub ahead of print]
[h=1]Detection of influenza antigenic variants directly from clinical samples using polyclonal antibody based proximity ligation assays.[/h] Martin BE[SUP]1[/SUP], Jia K[SUP]1[/SUP], Sun H[SUP]1[/SUP], Ye J[SUP]1[/SUP], Hall C[SUP]1[/SUP], Ware D[SUP]2[/SUP], Wan X[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Identification of antigenic variants is the key to a successful influenza vaccination program. The empirical serological methods to determine influenza antigenic properties require viral propagation. Here a novel quantitative PCR-based antigenic characterization method using polyclonal antibody and proximity ligation assays, or so-called polyPLA, was developed and validated. This method can detect a viral titer that is less than 1000 TCID[SUB]50[/SUB]/mL. Not only can this method differentiate between different HA subtypes of influenza viruses but also effectively identify antigenic drift events within the same HA subtype of influenza viruses. Applications in H3N2 seasonal influenza data showed that the results from this novel method are consistent with those from the conventional serological assays. This method is not limited to the detection of antigenic variants in influenza but also other pathogens. It has the potential to be applied through a large-scale platform in disease surveillance requiring minimal biosafety and directly using clinical samples.
Copyright ? 2014 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Antigenic drift; Antigenic variant; HI; Influenza virus; Neutralization

PMID: 25546251 [PubMed - as supplied by publisher]


http://www.ncbi.nlm.nih.gov/pubmed/25546251
 
Back
Top Bottom